Allosteres to regulate neurotransmitter sulfonation.

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Catecholamine neurotransmitters influence human mood and behavior.
• Human sulfotransferase 1A3 (SULT1A3) inactivates key neurotransmitters through sulfonation.
• Targeting SULT1A3 offers a potential therapeutic strategy for neurological and psychiatric disorders.

Purpose of the Study:

• To identify and characterize a novel allosteric site on SULT1A3 for enzyme inhibition.
• To explore sulfonation as a mechanism for regulating neurotransmitter activity.
• To develop a predictive model for designing SULT1A3 allosteric inhibitors.

Main Methods:

• Spin-label-triangulation NMR was used to determine the structure of the allosteric site.
• Computational methods were employed to calculate free energy changes of the active-site cap.
• A series of allosteric inhibitors were designed, synthesized, and tested for SULT1A3 inhibition.

Main Results:

• A previously unknown allosteric site was discovered at the edge of the SULT1A3 active-site cap.
• Inhibitors designed using computational predictions demonstrated potent binding and progressive enzyme inhibition.
• Experimental results for inhibitor efficacy closely matched theoretical predictions.

Conclusions:

• The identified allosteric site provides a target for developing SULT1A3 inhibitors.
• A reliable heuristic for designing SULT1A3 allosteric inhibitors based on cap stabilization was established.
• Accurate prediction of free-energy changes in dynamic protein loops is feasible for drug design.